Pulmonary Fibrosis News Forums › Forums › Bionews Content › Flash Briefings & Podcasts › Blade Therapeutics Announced Its Acquisition of Atxco and Lead Anti-Fibrosis Candidate PAT-409

  • Flash Briefings & Podcasts

    Blade Therapeutics Announced Its Acquisition of Atxco and Lead Anti-Fibrosis Candidate PAT-409

    Posted by Pulmonary Fibrosis News Moderator on November 21, 2019 at 8:32 am

    Senior Director of Multichannel Content for Pulmonary Fibrosis News, Michael Morale, discusses how Blade Therapeutics announced its acquisition of Atxco, and its lead anti-fibrosis candidate PAT-409.

    Are you interested in learning more about Pulmonary Fibrosis? If so, please visit pulmonaryfibrosisnews.com/

    What do you think about this news? Listen to this flash briefing episode and share your thoughts in the comment section below!

    Pulmonary Fibrosis News Moderator replied 5 years, 1 month ago 1 Member · 0 Replies
  • 0 Replies

Sorry, there were no replies found.

Log in to reply.

Start of Discussion
0 of 0 replies June 2018
Now

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Invite this member to groups
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .